Trade OpGen, Inc. - OPGN CFD
Add to favourite- Summary
- Historical Data
Spread | 0.05 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.026179% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | 0.003957% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
Prev. Close | 0.58 |
Open | 0.58 |
1-Year Change | -39.58% |
Day's Range | 0.54 - 0.58 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Apr 24, 2024 | 0.54 | -0.03 | -5.26% | 0.57 | 0.58 | 0.53 |
Apr 23, 2024 | 0.58 | 0.00 | 0.00% | 0.58 | 0.58 | 0.57 |
Apr 22, 2024 | 0.58 | -0.02 | -3.33% | 0.60 | 0.60 | 0.57 |
Apr 19, 2024 | 0.59 | 0.00 | 0.00% | 0.59 | 0.60 | 0.57 |
Apr 18, 2024 | 0.58 | 0.02 | 3.57% | 0.56 | 0.58 | 0.54 |
Apr 17, 2024 | 0.56 | -0.03 | -5.08% | 0.59 | 0.61 | 0.56 |
Apr 16, 2024 | 0.61 | 0.00 | 0.00% | 0.61 | 0.62 | 0.59 |
Apr 15, 2024 | 0.61 | -0.02 | -3.17% | 0.63 | 0.64 | 0.59 |
Apr 12, 2024 | 0.65 | -0.01 | -1.52% | 0.66 | 0.68 | 0.64 |
Apr 11, 2024 | 0.69 | 0.02 | 2.99% | 0.67 | 0.71 | 0.64 |
Apr 10, 2024 | 0.68 | 0.01 | 1.49% | 0.67 | 0.69 | 0.65 |
Apr 9, 2024 | 0.68 | -0.04 | -5.56% | 0.72 | 0.74 | 0.67 |
Apr 8, 2024 | 0.76 | 0.05 | 7.04% | 0.71 | 0.81 | 0.70 |
Apr 5, 2024 | 0.69 | 0.05 | 7.81% | 0.64 | 0.70 | 0.64 |
Apr 4, 2024 | 0.64 | 0.02 | 3.23% | 0.62 | 0.71 | 0.61 |
Apr 3, 2024 | 0.63 | 0.05 | 8.62% | 0.58 | 0.65 | 0.56 |
Apr 2, 2024 | 0.59 | 0.02 | 3.51% | 0.57 | 0.64 | 0.55 |
Apr 1, 2024 | 0.57 | -0.09 | -13.64% | 0.66 | 0.66 | 0.55 |
Mar 28, 2024 | 0.67 | 0.02 | 3.08% | 0.65 | 0.72 | 0.63 |
Mar 27, 2024 | 0.69 | 0.08 | 13.11% | 0.61 | 0.71 | 0.60 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
OpGen, Inc. Company profile
OpGen, Inc., a precision medicine company, engages in developing molecular information products and services in the United States and internationally. The company utilizes molecular diagnostics and informatics to help combat infectious diseases. It also helps clinicians with information about life threatening infections, enhance patient outcomes, and decrease the spread of infections caused by multidrug-resistant microorganisms. The company''s products include Acuitas AMR Gene Panel, a vitro diagnostic test for the detection and identification of various bacterial nucleic acids and genetic determinants of antimicrobial resistance (AMR) from bacterial colonies isolated from any specimen; and QuickFISH and PNA FISH diagnostic test products for the identification of various infectious pathogens, as well as SARS CoV-2 test kits. In addition, it offers Acuitas Lighthouse informatics systems, a cloud-based HIPAA compliant informatics, which combines clinical lab test results with patient and hospital information to provide analytics and insights to enable manage MDROs in the hospital and patient care environment; Unyvero Platform, an automated sample-to-answer molecular diagnostics platform that integrates automated sample preparation, analysis, and identification of disease relevant pathogens and antibiotic resistance markers; and ARES Technology Platform, including ARESdb, which provides next generation sequencing based and artificial intelligence powered, cloud-based bioinformatics solutions to generate AMR profiles, as well as predict antimicrobial susceptibility test results. OpGen, Inc. has a strategic collaboration with the New York State Department of Health to develop a solution to detect, track, and manage antimicrobial-resistant infections at healthcare institutions. The company was incorporated in 2001 and is based in Rockville, Maryland.Industry: | Biotechnology & Medical Research (NEC) |
9717 Key West Avenue
Suite 100
20850
News
We’re partnering with Newsquawk
Filter out the noise and focus on the news that matters.
08:32, 23 April 2024US Earnings Season: Tesla, Alphabet, Meta Platforms and Microsoft
The first lot of Wall Street’s mega-cap tech companies report in the coming week. We preview what to expect from Tesla, Alphabet, Meta, and Microsoft’s quarterly results.
15:56, 22 April 2024Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported
Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.
07:56, 17 April 2024US Earnings Season : JP Morgan, Citigroup, Wells Fargo
The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.
16:03, 11 April 2024Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues
The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
09:22, 11 April 2024US CPI Preview: US inflation expected to grind lower amid fears about sticky prices
US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).
15:11, 9 April 2024How escalating geopolitical tensions are impacting oil markets
The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.
13:34, 4 April 2024People also watch
Still looking for a broker you can trust?
Join the 610,000+ traders worldwide that chose to trade with Capital.com